ABCMAbcam plc

Nasdaq abcam.com


$ 23.98 $ 0.01 (0.04 %)    

Tuesday, 05-Dec-2023 15:59:41 EST
QQQ $ 431.01 $ 6.55 (1.54 %)
DIA $ 382.27 $ 1.39 (0.36 %)
SPY $ 508.26 $ 4.77 (0.95 %)
TLT $ 88.26 $ 0.46 (0.52 %)
GLD $ 216.60 $ 0.70 (0.32 %)
$ 23.99
$ 23.98
$ 0.00 x 0
$ 0.00 x 0
$ 23.98 - $ 24.00
$ 12.48 - $ 25.32
7,430,229
na
5.5B
$ 0.87
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles

Abcam plc (NASDAQ:ABCM) (‘Abcam', the ‘Group' or the ‘Company'), a global leader in the supply of life science rese...

 rbc-capital-maintains-sector-perform-on-abcam-lowers-price-target-to-24

RBC Capital analyst Alistair Campbell maintains Abcam (NASDAQ:ABCM) with a Sector Perform and lowers the price target from $...

Core News & Articles

Commenting on the report, Jonathan Milner issued the following statement: "I welcome Glass Lewis's scrutiny of the pre...

Core News & Articles

Jonathan Milner releases presentation to Abcam plc shareholders, outlining reasons to reject Danaher's bid and strategic vi...

 rbc-capital-reiterates-sector-perform-on-abcam-maintains-25-price-target

RBC Capital analyst Alistair Campbell reiterates Abcam (NASDAQ:ABCM) with a Sector Perform and maintains $25 price target.

Core News & Articles

Abcam plc (NASDAQ:ABCM) (‘Abcam', the ‘Group' or the ‘Company'), a global leader in the supply of life science rese...

 danaher-bears-the-brunt-of-macro-woes-analyst-flags-lower-demand-reduced-funding--weakness-in-china

KeyBanc Capital Markets analyst Paul Knight reiterated the Overweight rating on Danaher Corporation (NYSE: DHR), 

Core News & Articles

Abcam plc (NASDAQ:ABCM) ("Abcam" or the "Company"), notes today's announcement by Dr. Jonathan Milner. The ...

Core News & Articles

Dr. Jonathan Milner opposes Danaher's acquisition of Abcam and calls for EGM to replace Board

 abcam-h1-sales-22147m-down-from-24075m-yoy

Abcam (NASDAQ:ABCM) reported $221.47 million in sales this quarter. This is a 8.01 percent decrease over sales of $240.75 milli...

 svb-leerink-downgrades-abcam-to-market-perform-announces-24-price-target

SVB Leerink analyst Puneet Souda downgrades Abcam (NASDAQ:ABCM) from Outperform to Market Perform and announces $24 price ta...

 danahers-strategic-abcam-deal-boosts-growth-at-a-reasonable-price-analyst

Monday, Danaher Corporation (NYSE: DHR) had agreed to acquire Abcam plc (NASDAQ: ABCM) for $24.00 per share in cash, or a total...

 beaten-down-covid-19-vaccine-partner-stock-catalent-finalizes-deal-with-activist-investor-reports-mixed-q4-earnings

Catalent Inc (NYSE: CTLT), valued at around $8 billion, has finalized a deal with activist investor Elliott Investment Manageme...

 danaher-acquires-abcam-in-57b-deal-abcm-is-sliding-below-deal-price---heres-why

Danaher Corporation (NYSE: DHR) has 

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION